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ABSTRACT 
Purpose: Aerosol inhalation therapy is one of the methods to treat rhinosinusitis. However the 20 
topical drug delivery to the posterior nose and paranasal sinuses shows only limited 
efficiency. A precise sinusal targeting remains a main challenge for aerosol treatment of sinus 
disorders. This paper proposes a comparative study of the nasal deposition patterns of micron 
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and submicron particles using planar gamma-scintigraphy imaging vs. a new 3-dimensional 
(3D) imaging approach based on SPECT-CT measurements. 25 
Methods: Radiolabelled nebulizations have been performed on a plastinated model of human 
nasal cast coupled with a respiratory pump. First, the benefits provided by SPECT-CT 
imaging were compared with 2D gamma-scintigraphy and radioactive quantification of 
maxillary sinus lavage as reference for the sonic 2.8 µm aerosol sinusal deposition. Then, the 
impact on nasal deposition of various airborne particle sizes was assessed. 30 
Results: The 2D methodology overestimates aerosol deposition in the maxillary sinuses by a 
factor 9 whereas the 3D methodology is in agreement with the maxillary sinus lavage 
reference methodology. Then with the SPECT-CT approach we highlighted that the higher 
particle size was mainly deposited in the central nasal cavity contrary to the submicron 
aerosol particles (33.8 ± 0.6% of total deposition for the 2.8 µm particles vs. 1 ± 0.3% for the 35 
230 nm particles). 
Conclusion: Benefits of SPECT/CT for the assessment of radiolabelled aerosol deposition in 
rhinology are clearly demonstrated. This 3D methodology should be preferentially used for 
scintigraphic imaging of sinusal deposition in Human. 
 40 
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1. Introduction 50 
The treatment of nasal infections can be challenging (Baroody, 2007; Fokkens et al., 
2012). Delivering antibiotics by aerosol straight through the site of infection is a common 
strategy (Costantino et al., 2007). Different regions are targeted for these pathologies: the 
middle meatus as the major site of drainage for sinuses, the maxillary and ethmoid sinuses 
and the superior and posterior region of the central nasal cavity (Laube, 2007). 55 
Thanks to ongoing development of medical technology, medical imaging has been 
increasingly used in respiratory research. Deposition studies are essential in the field of 
aerosols. Nowadays, one of the main experimental methodologies proposed in the literature 
consist in using radioactive aerosol associated with 2-dimensional (2D) gamma-scintigraphy 
imaging (Möller et al., 2011; Vecellio et al., 2011). Indeed, nuclear medicine is commonly 60 
used to determine the aerosols deposition patterns. Gamma scintigraphy uses radiolabelled 
formulations with gamma-ray emitting radionucleides. Different ventilation markers can be 
used such as Diethylene-Triamine Penta-Acetic Acid (DTPA) labeled with Technetium 99m 
(
99m
Tc), 
81m
Krypton gas or Technegas. The distribution of the radioactive aerosol is generally 
assessed by a single-head gamma scintigraphy. However, planar gamma camera imaging 65 
provides 2D nuclear data without any visualization of anatomical features such as maxillary 
sinuses (Möller et al., 2008, 2010a, 2010b; Moller et al., 2011; Vecellio et al., 2011). 
Currently, SPECT is a 3D imaging modality routinely used in clinical nuclear 
medicine. The 3D informations implement other methods in airway research by giving 
topographical informations, visualization of functional or structural modifications, a sampling 70 
of the whole organ and potential for in vivo imaging in a repeated prospective nature. In 
research field, 3D imaging techniques (e.g. SPECT) have the potential to give more detailed 
data on regional aerosol deposition. Over the last few years combined SPECT-CT scanners 
have become available. The concomitant acquisition without moving the patient and on the 
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same equipment improves the alignment. The combination of SPECT and CT enables us to 75 
assess regional function in relation to structural changes and so the action ways of drugs in 
airway diseases. Clinically, SPECT has considerably improved 2D measurement of 
radioactive aerosol deposition. The applications are very wide in the development of 
therapeutic aerosols and in the investigation of mucociliary clearance particularly for 
bronchiectasis or cystic fibrosis (Eberl et al., 2001, 2006; Fleming et al., 2011; King, 2011). 80 
In the first part, this paper presents an innovative 3D-imaging approach using SPECT-
CT compared to 2D gamma-scintigraphy and radioactive quantification of maxillary sinus 
lavage. Experiments were performed using a ventilated realistic plastinated nasal cast and an 
air-jet nebulizer generating 2.8 µm airborne particle size to accurately determine the potential 
benefits provided by SPECT-CT compared to planar scintigraphy. In a second part, nasal and 85 
sinus deposition were described for different sizes of aerosols using SPECT-CT imaging. The 
combination to CT scans accurately relates 3D nuclear images to anatomy. Thus, the impact 
of aerosol size and then acoustic frequency on the regional depositions especially in the 
different sinusal compartments was accurately evaluated. 
 90 
2. Materials and methods 
2.1 Plastinated nasal model and aerosol inhalation 
Experiments were performed using a human plastinated nasal cast obtained by a 
specific plastination technique (Croce et al., 2006; Durand et al., 2001). The specimen has 
been obtained from a deceased man who donated his body to the Saint-Etienne Anatomy 95 
Laboratory in accordance with law and ethics committee. The obtained nasal casts do not 
present significant tissue retraction, the mucosa in particular is conserved. This specimen is 
dedicated to functional studies and has been anatomically and aerodynamically validated in a 
previous study (Durand et al., 2011a). 
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The plastinated nasal cast is ventilated as close as possible to in vivo conditions. A respiratory 100 
pump (Pari GmbH, Compas II) allowed us to simulate in vivo aerosol administration, i.e. a 
nasal inhalation and then mouth exhalation. As a compromise, the breathing parameters 
chosen correspond to male adult physiology at rest (breathing rates of 15 per minute, tidal 
volume (Vt) of 500 mL, inspiratory-to-expiratory time I/E ratio of 2/3, ET deadspace of 21 
ml, tracheal diameter of 1 cm, principal bronchus diameter of 0.8 cm) (Booker, 2009; Criée et 105 
al., 2011; Flesch and Dine, 2012). A specific one-way valve simulating the soft palate 
(resistance = 0.13  0.07 cm H2O/min/L, mean  SD measured for flow rates of 1 to 15 
L/min) was connected to a T-piece equipped with an absolute filter, a tube 15 cm long tube 
simulating the trachea, and a second absolute filter. The whole mecanism was placed between 
the model and the pump as shown on the experimental set-up (Figure 1). 110 
The plastinated nasal cast allowed free exterior access to the maxillary sinuses (via the 
cheeks, zygomatic and maxillary bones) to assay the nebulized drug deposited using 
maxillary sinus lavage as previously described (Durand et al., 2011b). During the inhalation 
experiments, two movable plastic plates were used to hermetically close the exterior access of 
both maxillary sinuses. 115 
 
2.2 Nebulization systems 
Commercial jet medical nebulizers are used to generate micrometric and 
submicrometric aerosols. These nebulizers are an Atomisor NL11 (DTF Medical, France), a 
modified Sidestream (Philips Respironics, Ref 12NEB400, England), and a Nanoneb (DTF 120 
Medical, France) operating at a flow rate of 6 L.min
-1
.  
The nebulization system is associated with an AOHBOX air source compressor ATOMISOR 
AUTOSONIQUE BOX (Diffusion Technique Française, DTF Medical, Saint-Etienne, 
France). During nebulization with the NL11 device, a discontinuous 100 Hz acoustic airflow 
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can be added to the aerosol (NL11S). The different nebulizers are connected to a nasal plug 125 
(C28 medium size, DTF Medical, France) usually employed in clinical practice. This plug 
ensures the interface connection between nebulizer and plastinated cast’s nostrils. 
The aerosol size measurement was conducted with sodium fluoride (NaF; 2.5 wt%; 4 mL), a 
chemical tracer recommended by European standard procedure (NF EN 13544-1) using an 
Electrical Low Pressure Impactor (ELPI, Dekati Ltd., Finland) as described in a previous 130 
study (Durand et al., 2011b). 
 
2.3 Aerosol deposition 
To emphasize the potential benefits of SPECT-CT, two nuclear imaging methodologies were 
performed to assess nasal and sinus deposition: 135 
- Planar scintigraphy with a single-head gamma camera associated with a previous gas 
ventilation study using 81mKr to determine Regions Of Interest (ROIs) (Möller et al., 2008; 
Vecellio et al., 2011). 
- 3D aerosol deposition using SPECT/CT imaging. 
For the methodologies comparison, experiments were performed with the 2.8 µm aerosol with 140 
100 Hz acoustic airflow (NL11S). 
To evaluate the deposition patterns, the other types on nebulizers were compared using only 
the 3D imaging approach (2.8 µm NL11/NL11S, 550 nm Sidestream and 230 nm Nanoneb). 
 
2.3.1 Assessing aerosol deposition by 2D imaging 145 
Gamma camera imaging and 99mTc-DTPA aerosol deposition  
For each experiment, NL11S nebulizers were loaded with 74MBq/3mL of 99mTc-DTPA 
(TechneScan DTPA, Diethyl-Triamine-Penta-Acetic acid, Mallinckrodt Medical, Petten, 
Netherlands); the duration of nebulization was limited to 10 min. The scintigraphic images 
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were recorded with a planar gamma camera (resolution 128x128) using a single detector 150 
equipped with a low-energy, high-resolution collimator: E-cam camera (Siemens, Germany - 
397mm x 500mm collimator), tested monthly for uniformity (UFOV 357mm x 475mm, 
CFOV 268mm x 356mm). Ventilation scintigraphy was performed before the aerosol 
administration to precisely define three different ROIs: central nasal cavity, ethmoid and 
maxillary sinuses regions. 81mKr gas (81Rb-81mKr generator, Covidien, Petten, The 155 
Netherlands) was continuously administered through the nostrils of the plastinated nasal cast 
to measure the nasal cavity ventilation. Three images were acquired during 2 min of gas 
ventilation: (1) a lateral view of the nasal cavities to determine central nasal cavity and 
ethmoid regions; (2) a coronal section of the nasal cavities and (3) a coronal section of the 
nasal cavities, using an addition of 100Hz sound (AOLH box compressor) during gas 160 
administration to determine the maxillary sinus region. 
Before aerosol inhalation, the initial radioactive amount charged in the nebulizer was 
quantified (scintigraphy image acquired over a 1-min period). After aerosol inhalation, the 
following images of the plastinated nasal cast were acquired over a 2-min period: (1) a lateral 
view showing aerosol deposition in the nasal cavities; (2) a coronal view showing deposition 165 
in the central nasal cavity and maxillary sinuses. The ROIs were defined from the ventilation 
images using Siemens software for the central nasal cavity, and ImageJ software (ImageJ 
1.43U, National Institutes of Health, USA) for ethmoid and maxillary sinuses. The ethmoid 
region was defined as the upper half of the nasal region (lateral image), and the maxillary 
sinuses were defined as the regions seen from the coronal view (Vecellio et al., 2011). These 170 
ROIs were then applied to aerosol images to determine the radioactivity deposited in each 
region (nasal, ethmoid and maxillary sinus regions). The activity thus measured in the three 
ROIs was expressed in terms of the activity loaded into the nebulizer. All calculations also 
took into account the background radiation and physical decay of radioactivity. 
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 175 
Aerosol distribution in the nasal anatomical regions 
The gamma camera images were analyzed using ImageJ software. The distribution of the 
aerosol deposited in the nasal anatomical regions was analyzed along three axes: the x-axis 
from the nostrils to the cavum, the z-axis from the floor to the upper nasal cavities, and the y-
axis from the septum to the extremity of the maxillary sinuses. Distributions were normalized 180 
taking into account the pixel size and counted radioactivity. Statistical analyses were 
performed using StatXact® software (StatXact-3 3.0.2, Cytel Software Corporation, France). 
Non-parametric stratified Normal Score tests were used to compare deposition data for the 
three anatomical regions (central nasal cavity, ethmoid and maxillary sinuses). Strata (n=2) 
were determined by both nebulizers. 185 
 
2.3.2 Assessing aerosol deposition by a maxillary sinus reference rinsing method 
After a 2D image acquisition, the aerosol deposited in the maxillary sinuses of the plastinated 
nasal cast was also analyzed by radioactive counting using a rinsing method: the right and left 
maxillary sinuses were rinsed with 1 mL of distilled water; the liquid was collected in 190 
microtubes and the activity was counted (1 min) using an ISOCOMPT I gamma counter 
(MGM instruments, Hamden, USA). The activity deposited in the maxillary sinuses was 
expressed as a percentage of the nebulizer charge (measured with gamma camera). All 
calculations took into account background radiation, the physical decay of radioactivity, 
calibration and extraction factors. Maxillary sinus deposition data (dosages) were analyzed 195 
with Wilcoxon Mann-Whitney tests. 
 
2.3.3 Assessing aerosol deposition by 3D imaging 
Gamma camera imaging and 99mTc-DTPA aerosol deposition 
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SPECT generate a 3D description of a gamma-emitting radionuclide distribution using the 200 
data obtained from a rotating gamma camera. SPECT images were improved by the addition 
of anatomical image data. To increase the accuracy of the radioactivity distribution, the counts 
detected by the gamma camera were corrected for tissue attenuation improving the quality of 
quantification. SPECT and CT acquisitions were performed with a SYMBIA T2 variable 
angle dual detector SPECT with a 2-slice spiral CT for rapid accurate attenuation correction 205 
and anatomical mapping (SIEMENS, Knoxville, TN, USA). 
Nebulizers were filled with 400 megabecquerels (MBq) of DTPA-Technetium 99m (
99m
Tc) 
solution (DTPA Technecsan®, COVIDIEN-Mallinckrodt, ND) in a 4 mL syringe. The 
aerosolized fraction was evaluated for each nebulizer. Immediately after aerosol 
administration, each element was successively set up on the examining table in the center of 210 
the gamma cameras field. Planar images were obtained for the syringe (60-sec 
anterior/posterior), the nebulizer, the pulmonary filter, all accessory materials and the 
plastinated model (180-sec anterior/posterior). The background noise on planar images 
(256*256 image matrix, zoom 1) was reduced and suitable corrections were made to take into 
account the radioactive decay and the attenuation of gamma rays by tissues. Images obtained 215 
for the syringe, the nebulizer and the accessories were used to evaluate the quality control of 
nebulization experiment. We confirmed for each experiment that the total radioactivity 
deposited well corresponds to the total radioactivity nebulized. 
Without moving the plastinated nasal cast, a 3D SPECT acquisition was performed 
with 64 projection (2*32) images each of 30 seconds. Finally a CT was performed with the 220 
following parameters: 130 kV, 90 mAs, slice thickness 1.25 mm, increment 0.9 mm, pitch 
1.6, rotation time 1.5 s. A multimodality computer platform (Symbia net; Siemens) was used 
for image review and manipulation. Both the transmission and emission scans were 
reconstructed using 3D OSEM (8 subsets, 5 iterations), with a pre reconstruction smooth 
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using a 3D Butterworth filter (cutoff: 0.45 cycles/cm; order 5), 128×128 image matrix, zoom 225 
1.23 and pixel size of 3.9 mm. SPECT images were reconstructed using scatter correction 
(scatter energy window) and CT attenuation correction. CT and SPECT images were matched 
and fused into transaxial images. Different 3D regions of interest (ROI) are manually drawn 
on the CT images with the software: right maxillary sinus, left maxillary sinus, frontal 
sinuses, ethmoid sinuses, central nasal cavity and the global head. The nuclear activity was 230 
quantified in each 3D ROI. A qualitative evaluation of the deposition is also performed by a 
qualified Nuclear Medicine specialist. The nuclear activity hot spot is assessed on images. 
 
3. Results 
3.1. Aerosol properties and experimental set-up 235 
The different types of nebulizers used in this study lead to different mass median aerodynamic 
diameters, respectively expressed with their geometric standard deviation (± GSD): 2.8 ± 3.2 
µm for the NL11/NL11S, 550 ± 2.1 for the Sidestream and 230 ± 1.6 nm for the Nanoneb. 
The nebulizer output rates were also assed after 10 minutes of nebulization and expressed in 
percentage. Respectively 0.32 ± 0.03 for the Nanoneb, 1.11 ± 0.56 for the Sidestream and 240 
10.28 ± 1.76 for the NL11S (7.71 ± 1.24 for the NL11). The 100Hz acoustic airflow 
efficiently enhanced this aerosolized fraction for the micrometric aerosol. The Sidestream 
aerosolized fraction was three times higher than that of the Nanoneb and eight times under the 
aerosolized fraction of the NL11. 
The experimental set-up is shown on Figure 1. A quality control of each experiment was 245 
performed by radioactive counting of planar images obtained: the initial radioactivity load in 
the nebulizer before the nebulization experiment; the nasal cast, the nebulizer and accessories 
after the nebulization). We confirmed that the total radioactivity nebulized corresponds to the 
total radioactivity deposited in the set-up. Only a very low radioactivity loss, fewer than 6% 
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of the radioactive amount introduced initially into the nebulizer, was observed during the 250 
experiments (4 ± 2%). These data assess a good reproducibility of the aerosol deposition 
experiments. 
 
3.2. Aerosol deposition: 2D vs. 3D imaging 
The ROI determined by 2D imaging allows us only to discriminate ethmoid region and 255 
maxillary sinuses regions vs. nasal deposition. The precise definition of these 2D ROI was 
explained in a previous study (Vecellio et al., 2011). Even if this methodology takes into 
account the x, y and z directions, the ROIs have approximate outlines without detailed 
anatomical precisions. 
The definition of the 3D anatomical ROI determined by CT scans with radioactivity counting 260 
by SPECT was exposed in Figure 2A and B. With this methodology the ROIs outlines exactly 
correspond to the 3D scan anatomical visualization especially for the maxillary sinuses, 
frontal sinuses and central nasal cavity (Fig. 2A). Only the ethmoid sinuses delimitation is 
difficult due to the proximity of the central nasal cavity (Fig. 2B) but more realistic than in the 
2D description. 265 
 
For the methodologies comparison, experiments were performed with the 2.8 µm aerosol with 
100 Hz acoustic airflow (NL11S). The deposited fractions are presented in Table I for the 2D 
and 3D approaches. Results are expressed in terms of percentage of the radioactive amount 
introduced initially into the nebulizer. The aerosol deposition in the maxillary sinuses was 270 
compared to the reference maxillary sinus rinsing method. The radioactivity was detected in 
all sinusal liquids collected after 2D acquisition of images and was quantified as percentage of 
the radioactive amount introduced initially into the nebulizer. We emphasized a deposition of 
0.03%  0.02 in the maxillary sinuses of the plastinated nasal cast after nebulization for the 
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reference lavage. This amount of aerosol deposited in the maxillary sinuses was significantly 275 
lower than that predicted by the 2D image-processing method (p<0.05) which predicted 9.3 
times more aerosol deposited in maxillary sinuses than the in situ rinsing method (0.1% ± 0.1 
vs. 0.03%  0.002). However this amount is statistically equivalent to the deposition predicted 
by the SPECT-CT (0.03 ± 0.004% vs. 0.03%  0.002). This result confirms that the 
quantification of intrasinus deposition obtained using SPECT-CT is in agreement with the 280 
reference lavage method whereas the 2D planar scintigraphy methodology over-estimates 
deposition in maxillary sinuses. This over-estimation with the 2D methodology was also 
confirmed for the deposition in the central nasal cavity and ethmoid region (3.2 ± 0.3 vs. 2.38 
± 0.3 and 0.5% ± 0.1 vs. 0.03% ± 0.01 respectively). 
 285 
3.3. Aerosol deposition in nasal anatomical regions assessed by SPECT/CT 
Different types of nebulizers which have different aerosol metrologies were compared using 
SPECT/CT methodology: 230 nm for the Nanoneb, 550 nm for the Sidestream and 2.8 µm for 
the NL11. A 100 Hz acoustic effect was also assessed for the 2.8 µm particles (NL11S). 
Representative images of SPECT/CT (sinusal deposition) obtained for the different 290 
nebulizers are shown on Figure 3. It clearly demonstrates a huge deposition of aerosol in the 
central nasal cavity for the 2.8 micrometric aerosol (NL11 device) whereas the deposition was 
reduced in the case of submicrometric aerosol particularly for the 230 nm aerosol (Nanoneb). 
The acoustic frequency enhances the deposition into the maxillary sinuses where hot spot 
were found with the 2.8 µm aerosol (NL11S). In the right maxillary sinus, a deposition of 295 
0.166 ± 0.042 was found without sound vs. 0.224 ± 0.036 with a 100 Hz acoustic frequency. 
ROI were traced in order to quantify the deposition as already explained (Fig. 2). The 
CT images allowed a precise definition in 3D of the left and right maxillary sinuses, the 
ethmoid sinuses, the frontal sinuses and the central nasal cavity. The main difficulty 
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encountered was the precise delimitation of the ethmoid region as shown on Figure 2B. A 300 
ratio was established with the global deposition in the entire plastinated nasal cast and results 
were presented in Figure 4 expressed as percentage of total deposition. The percentage of total 
deposition in the central nasal cavity was significantly higher for the 2.8 µm aerosol (33.8 ± 
0.6%) while deposition was reduced for the 550 and 230 nm aerosol (respectively 1.3 ± 0.1% 
and 1 ± 0.3%). Only small amount of radioactivity was quantified in the other anatomical 305 
regions. Indeed, less than 1% of the total aerosol deposition was detected in the maxillary and 
ethmoid sinuses and non significant values in the frontal sinuses. However it clearly 
demonstrates a significant efficiency of the acoustic frequency of the NL11 nebulizer (2.8 
µm) to enhance aerosol deposition in the right maxillary sinus. 
 310 
4. Discussion 
This study clearly demonstrates the benefits of 3D imaging approach using SPECT/CT 
compared to planar gamma scintigraphy to assess aerosol sinus deposition in comparison to 
maxillary sinus lavage reference method. ROIs definition with the 2D methodology, based on 
anatomical means although inter-subject anatomical differences, appears unsatisfactory and 315 
the anatomical regions are not well-defined compared to CT datas available using the 3D 
approach. Finally results obtained with 2D imaging clearly demonstrate an overestimation of 
the intrasinus aerosol deposition compared to SPECT-CT 3D imaging. Indeed in 2D there is a 
clear difficulty for anatomical localization. Due to the low activity obtained in the maxillary 
sinuses compared to the strong activity in the nasal central cavity, a small error on ROI 320 
definition cause an important overestimation of maxillary sinuses deposition. 
As a matter of fact, the SPECT/CT methodology allows a precise anatomical 
definition of the ROI in 3D for the different region of interest (central nasal cavity, maxillary 
sinuses, ethmoid sinuses and frontal sinuses). The use of combined SPECT-CT scanning 
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clearly has some important advantages over planar gamma scintigraphy imaging. It was the 325 
only powerful nuclear medicine imaging method to accurately assess the aerosol deposition in 
ENT regions such as the maxillary sinuses. 3D radionuclide imaging combined with 
anatomical information from CT and computer analysis should become the new reference 
approach for applications requiring the assessment of regional aerosol deposition. This 
quantification methodology appears especially useful in avoiding overestimation of sinusal 330 
aerosol deposition compared to usual 2D imaging. However SPECT/CT is not without 
disadvantages. A main limitation involves a higher radiation dose because of the addition of 
CT. Taking into account our CT parameters, it corresponds to 1.66 mGy CTDi vol (computed 
tomography dose index volumic). CT add only 0.09 mSv to a planar scintigraphy (39 
mGy*cm for the entire head). The head is less radiosensitive than other organs such as lungs. 335 
Moreover SPECT/CT also requires a longer acquisition time. However a plastinated model do 
not have the same disadvantages as healthy volunteers and the results are more reproducible. 
 
Secondly SPECT/CT seems to be the nuclear imaging method most predictive of 
sinusal active substance deposition. Indeed, the SPECT/CT results are in excellent agreement 340 
with the radioactivity quantification of maxillary sinus lavage. A mean of 0.03 ± 0.004% was 
obtained for SPECT/CT and 0.03 ± 0.02% for the rinsing method (in terms of percentage of 
the radioactive amount introduced initially in the NL11S nebulizer). Moreover the SPECT/CT 
results were also quite relevant to results obtained for gentamicin maxillary sinus lavage 
performed in a previous study (Durand et al., 2012). It was demonstrated that a mean mass of 345 
3.31 µg of antibiotic were deposited in the maxillary sinuses of the same nasal cast using the 
NL11 device. In terms of percentage of the amount of gentamicin introduced initially into the 
nebulizer, this result corresponds to 0,001%. All things considered, using a same nasal cast 
and nebulizer, we proved that the Tc-DTPA sinusal deposition measured by SPECT-CT 
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overestimates ten times the gentamicin deposition (0.03 ± 0.004%), whereas the Tc-DTPA 350 
deposition measured by 2D scintigraphy overestimates a hundred times the gentamicin 
deposition (0.1 ± 0.1%). Thus, SPECT/CT appeared as the most predictive nuclear medicine 
technique to assess antibiotic sinusal deposition. However, the quantification deviation 
between SPECT-CT and gentamicin maxillary sinus lavage could be due to the structural 
differences of the markers used, on the one hand gentamicin (an aminoside) and on the other 355 
hand a radioactive molecule (Tc-DTPA). However SPECT/CT seems to be an efficient 
methodology of predicting an active substance deposition by aerosoltherapy even with a ten 
times overestimation which is better than 2D scintigraphy. 
Finally the last part of this study employed this innovative SPECT/CT methodology to 
describe the nasal and sinusal deposition of different aerosol sizes (micrometric vs. 360 
nanometric). This study clearly demonstrates that 230 nm aerosolized particles with a nasal jet 
nebulizer are not efficiently deposited in the central nasal cavity (under 2% of the initial 
charge). Micrometric particles (2.8 µm), on the contrary, are efficiently deposited in the 
central nasal cavity (30% of the initial charge). Moreover the addition of a 100 Hz acoustic 
airflow to the 2.8 µm aerosol significantly enhance the deposition in maxillary sinuses which 365 
represent a high interest for sinusitis pathologies treatment. 
 
5. Conclusion 
SPECT/CT seems to be an efficient methodology for the prediction of sinusal deposition of an 
active substance by nebulization. Sensibility of the radioactivity detection and efficiency of 370 
the SPECT/CT imaging allow us to emphasize the aerosol size dependence of the deposition 
in different ENT regions. Compared to planar scintigraphy, benefits of SPECT/CT for the 
assessment of radiolabelled aerosol deposition in rhinology are clearly demonstrated. This 3D 
methodology should be preferentially used for scintigraphic imaging of sinusal deposition in 
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Human. Moreover, nebulizers generating micro-sized aerosol (2.8 µm) coupled with a 100 Hz 375 
acoustic airflow appear efficient when targeting maxillary sinuses. 
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Aerosol deposition Reference 
  
2D imaging 
3D imaging 
(SPECT-CT) 
in situ rinsing 
method 
NL11S 
2.8 µm 
Central nasal 
cavity 
3.2 ± 0.3 2.38 ± 0.3 
 
Ethmoid 0.5 ± 0.1 0.03 ± 0.01 
 
Maxillary 
sinuses  
0.1 ± 0.1 0.03 ± 0.004 0.03 ± 0.02 
 
Table I: Deposited fractions for the 2D and 3D approaches compared to the in situ rinsing 
method after nebulization with NL11S (2.8 µm). Results are expressed in terms of percentage 
of the radioactive amount introduced initially into the nebulizer (mean  SD). 
 
 
 
Figure 1: Schematical experimental set-up for nebulization simulating an inspiration by the 
nose and exhalation trough the mouth thanks to the respiratory pump. 
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Figure 2: Definition of the 3D imaging anatomical ROIs. 
(A) ROI determined by CT scans with radioactivity visualization by SPECT: maxillary 
sinuses (red and green), central nasal cavity (yellow) and frontal sinuses (purple). 
(B) Ethmoid sinuses delimitations (bright blue), maxillary sinuses (red and green), central 
nasal cavity (dark blue) and frontal sinuses (yellow). 
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NL11 
2.8µm 
Nanoneb 
230 nm 
Sidestream 
550 nm 
NL11S 
2.8 µm 
199  320 178  
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Figure 3: Illustrative SPECT/CT fused images obtained for each size of aerosol (different type 
of nebulizer): 2.8 µm (NL11 or NL11S), 550 nm (Sidestream) and 230 nm (Nanoneb). 
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Figure 4: A) Aerosol deposition profile expressed in percentage of total deposition for each 
size of aerosol (different type of nebulizer) in the different anatomical region of interest (Left 
and right maxillary sinuses, ethmoid and frontal sinuses and central nasal cavity). The 2.8 µm 
NL11S condition corresponds to the addition of a 100 Hz acoustic airflow during 
nebulization. B) is an enlargement on the sinuses data. 
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Supplementary Information: Experimental set-up for nebulization. A and B corresponds to 
photography of the set-up in the Nuclear Medicin department (CHU Saint-Etienne). 
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